Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmpeak Energy Regulatory News (AMP)

Share Price Information for Ampeak Energy (AMP)

Share Price is delayed by 15 minutes
Get Live Data
3.00    0.00 (0.00%)
Bid:
2.80
Ask:
3.20
Spread: 0.40 (14.286%)
Market Cap: £21.68m
AMP Live PriceLast checked at - London Stock Exchange

Intraday Ampeak Energy Share Chart

Update on Data Tern Patent Litigation

13 Apr 2011 07:00

RNS Number : 8002E
Amphion Innovations PLC
13 April 2011
 



Amphion Innovations plc

Update on U.S. Subsidiary, DataTern, Inc., Patent Litigation

 

 

London and New York, 13 April 2011 - DataTern, Inc., a wholly-owned subsidiary of Amphion Innovations plc (AIM: AMP) ("Amphion" or "the Company"), has successfully obtained settlements from suits brought in the U.S. against several, multi-national companies, for enforcement of its U.S. Patents 5,937,402 and 6,101,502 covering Object to Relational Database Mapping technology. Last week, Microsoft Corporation (NASD: MSFT) brought suit against DataTern claiming these patents are not infringed by Microsoft technology and are invalid. DataTerrn will strongly refute these claims by Microsoft and continue to enforce these patents against other infringers.

 

These patents are entitled to a presumption of validity and the 6,101,502 patent successfully completed a re-examination procedure in the U.S. Patent and Trademark Office in 2009. All 18 claims of this patent were reaffirmed and 26 new claims were added.

 

Richard Morgan, CEO of Amphion, said:

 

"DataTern has reached settlements with over 25 companies for over $17 million in license fees using its patented Object to Relational Database Mapping technology. We will vigorously defend the validity, and intend to prove infringement, of the DataTern patents."

 

 

For further information please contact:

Amphion Innovations

Charlie Morgan

+1 212 210 6224

 

Cardew Group

Tim Robertson

+44 (0)20 7930 0777

 

Seymour Pierce Limited, Nominated Advisor

Freddy Crossley/ Mark Percy

+44 (0)20 7107 8000

 

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number that grows rapidly each year.

On the web: www.amphionplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBIGDSSBBBGBD
Date   Source Headline
13th Nov 20067:01 amRNSAcquisition
7th Nov 200610:24 amRNSRe: Partner Company
2nd Nov 20064:36 pmRNSDirector/PDMR Shareholding
24th Oct 20069:03 amRNSDirector/PDMR Shareholding
14th Sep 20067:00 amRNSWellGen CEO
12th Sep 20067:00 amRNSChange of Adviser
7th Sep 20067:01 amRNSInterim Results
22nd Aug 20064:00 pmRNSFireStar Software, Inc
17th Aug 20067:01 amRNSAdditional Shares Placed
9th Aug 20061:43 pmRNSIssue of Equity
24th Jul 20067:02 amRNSSeries C Financing
12th Jun 20064:58 pmRNSResult of AGM
8th Jun 20067:03 amRNSAGM Statement
8th Jun 20067:01 amRNSAppointment
6th Jun 20067:01 amRNSRe Agreement
5th Jun 20063:16 pmRNSThe Shafallah Center
2nd Jun 20065:01 pmRNSDr David Evans
1st Jun 20067:00 amRNSAnnual Report and Accounts
23rd May 20067:00 amRNSDirector/PDMR Shareholding
22nd May 20061:41 pmRNSDirector/PDMR Shareholding
19th May 20065:12 pmRNSDirector Share Transaction
15th Mar 20069:25 amRNSCompletion of a Financing
8th Mar 20067:04 amRNSFinal Results
2nd Mar 20069:12 amRNSMotif BioSciences
27th Feb 20064:56 pmRNSNotice of Results
23rd Feb 20067:02 amRNSRe: WellGen Financing
3rd Jan 20067:01 amRNSAdditional Investments
5th Dec 200512:48 pmRNSDirector Shareholding
10th Oct 20057:00 amRNSAcquires a stake
21st Sep 20057:00 amRNSStake in Spin-Out Company
30th Aug 20057:00 amRNSAmphion Invests in WellGen
25th Aug 20054:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.